GovChime
AWARDPURCHASE ORDERSmall business

Purchase order 75N93019P01122A&G PHARMACEUTICAL, INC.

Overview

Award facts

Net obligations
Fully de-obligated
The obligations recorded on this award were later withdrawn.
Outlays (paid to date)
$0
$0
Period of performance
Aug 30, 2019 to Apr 3, 2024
Ended
Modifications
1
Latest action May 15, 2024
Contract type
Purchase order
PIID 75N93019P01122

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

MONOCLONAL ANTIBODY PRODUCTION OF PVS230

Dates and value

Award date
Signed on Aug 30, 2019
Potential end of performance
Apr 2, 2024

Obligations by fiscal year of action

  • FY2024: -$14,786 (de-obligation)
  • FY2019: $14,786

Total across 2 fiscal years: $0

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded May 15, 2024. View on USAspending · Recipient on SAM.gov

Recipient

LocationCOLUMBIA, MD
UEISN6SWFABJXL1
CAGE code1T9L5
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt

Business types and certifications

For-profit organizationCorporation (not tax-exempt)Manufacturer of goods

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Bethesda, Montgomery County, Maryland 20814-2903
Congressional district (place of performance)
MD-08As reported at the time of the action

Classification and competition

Classification

Product or service (PSC)
6505DRUGS AND BIOLOGICALS (product)

Competition

Extent competed
Competed under SAPF
Solicitation procedures
Simplified acquisitionSP1
Set-aside
Small business set aside - totalSBA
Contract pricing
Firm fixed priceJ
Offers received
3

Contract details

Subcontracting plan
Plan not requiredB
Commercial procedures
Commercial products/servicesA
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Aug 30, 2019Base obligation at award: $14,786
Latest action
May 15, 2024 — Funding onlyModification P00001; obligation change -$14,786; funding only: changes obligations, not scope
Latest funding action
May 15, 2024 — Funding onlyModification P00001; obligation change -$14,786; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Funding only1
2 actions recorded, Aug 30, 2019 to May 15, 2024; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$14,786
Latest action: change in base and all options
-$14,786

Socio-economic and policy

Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Mfg in U.S.D

Structure

Award or IDV
Award
Award type
Purchase orderB
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
2

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2019/2019-0885-000
Object classes
  • 22.0: Transportation of things
  • 26.0: Supplies and materials
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression